Zobrazeno 1 - 10
of 84
pro vyhledávání: '"McCabe MG"'
Autor:
Smith, L, Stiller, CA, Aitken, JF, Hjalgrim, LL, Johannesen, T, Lahteenmaki, P, McCabe, MG, Phillips, R, Pritchard-Jones, K, Steliarova-Foucher, E, Winther, JF, Woods, RR, Glaser, AW, Feltbower, RG
Despite improved survival rates, cancer remains one of the most common causes of childhood death. The International Cancer Benchmarking Partnership (ICBP) showed variation in cancer survival for adults. We aimed to assess and compare trends over time
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::410784a8ef4e65284f66358845154cb1
https://eprints.whiterose.ac.uk/178009/1/ijc.33774.pdf
https://eprints.whiterose.ac.uk/178009/1/ijc.33774.pdf
Autor:
Fraser, J, Fardus‐Reid, F, Irvine, L, Elliss‐Brookes, L, Fern, L, Cameron, AL, Pritchard‐Jones, K, Feltbower, RG, Shelton, J, Stiller, C, McCabe, MG
Background Oral etoposide is commonly used in palliative treatment of childhood and young adult cancer without robust evidence. We describe a national, unselected cohort of young people in England treated with oral etoposide using routinely collected
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::a4de6bb386d3f2634fa9dacb07a18de8
https://eprints.whiterose.ac.uk/176415/1/pbc.29204.pdf
https://eprints.whiterose.ac.uk/176415/1/pbc.29204.pdf
Autor:
de Rojas T, Kasper B, Van der Graaf W, Pfister SM, Bielle F, Ribalta-Farrés MT, Shenjere P, Preusser M, Fröhling S, Golfinopoulos V, Morfouace M, McCabe MG
Publikováno v:
INTERNATIONAL JOURNAL OF CANCER
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
For most adolescent and young adult (AYA) cancers, age-specific molecular features are poorly understood. EORTC-SPECTA, an academic translational research infrastructure for biomaterial collection, will explicitly recruit AYA patients and will theref
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::70f924ad2e9d570fb7926d6def5851b9
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=16552
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=16552
Autor:
Bright, CJ, Reulen, RC, Winter, DL, Stark, DP, McCabe, MG, Edgar, AB, Frobisher, C, Hawkins, MM
Publikováno v:
Bright, C J, Reulen, R C, Winter, D L, Stark, D P, McCabe, M G, Edgar, A B, Frobisher, C & Hawkins, M M 2019, ' Risk of subsequent primary neoplasms in survivors of adolescent and young adult cancer (Teenage and Young Adult Cancer Survivor Study) : a population-based, cohort study ', The Lancet Oncology, vol. 20, no. 4, pp. 531-545 . https://doi.org/10.1016/S1470-2045(18)30903-3
Background: Few studies have investigated the risks of subsequent primary neoplasms after adolescent and young adult (AYA) cancer. We investigated the risks of specific subsequent primary neoplasms after each of 16 types of AYA cancer. Methods: The T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::f2a5b7349384b902013be12604590405
https://eprints.whiterose.ac.uk/143396/3/1-s2.0-S1470204518309033-main.pdf
https://eprints.whiterose.ac.uk/143396/3/1-s2.0-S1470204518309033-main.pdf
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Gerrand C; Bone and Soft Tissue Tumour Service, Royal National Orthopaedic Hospital, Stanmore, Middlesex, HA7 4LP, UK. Craig.gerrand@nhs.net., Amary F; Bone and Soft Tissue Tumour Service, Royal National Orthopaedic Hospital, Stanmore, Middlesex, HA7 4LP, UK., Anwar HA; Bone and Soft Tissue Tumour Service, Royal National Orthopaedic Hospital, Stanmore, Middlesex, HA7 4LP, UK., Brennan B; The Christie NHS Foundation Trust, Manchester, M20 4BX, UK., Dileo P; Department of Oncology, University College London Hospital NHS Foundation Trust, London, NW1 2BU, UK., Kalkat MS; Department of Thoracic Surgery, Queen Elizabeth Hospital, Birmingham, B15 2GW, UK., McCabe MG; The Christie NHS Foundation Trust, Manchester, M20 4BX, UK., McCullough AL; Department of Orthopaedics, Woodend Hospital, Eday Road, Aberdeen, AB15 6XS, UK., Parry MC; Royal Orthopaedic Hospital, Bristol Road South, Birmingham, B31 2AP, UK., Patel A; Royal Orthopaedic Hospital, Bristol Road South, Birmingham, B31 2AP, UK., Seddon BM; Department of Oncology, University College London Hospital NHS Foundation Trust, London, NW1 2BU, UK., Sherriff JM; Cancer Centre, Queen Elizabeth Hospital, Birmingham, UK., Tirabosco R; Bone and Soft Tissue Tumour Service, Royal National Orthopaedic Hospital, Stanmore, Middlesex, HA7 4LP, UK., Strauss SJ; Department of Oncology, University College London Hospital NHS Foundation Trust, London, NW1 2BU, UK.
Publikováno v:
British journal of cancer [Br J Cancer] 2024 Nov 16. Date of Electronic Publication: 2024 Nov 16.
Autor:
Gaspar N; Department of Oncology for Child and Adolescent, Gustave Roussy Cancer Campus, Villejuif, France., Hung GY; Department of Pediatrics, Taipei Veterans General Hospital, Taipei, Taiwan., Strauss SJ; London Sarcoma Service, University College London Hospital NHS Trust, London, United Kingdom., Campbell-Hewson Q; The Great North Children's Hospital, Royal Victoria Infirmary, Newcastle Upon Tyne, United Kingdom., Dela Cruz FS; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Glade Bender JL; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Koh KN; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul, Republic of Korea., Whittle SB; Department of Pediatrics, Texas Children's Cancer Center, Baylor College of Medicine, Houston., Chan GC; Department of Paediatrics and Adolescent Medicine, School of Clinical Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China., Gerber NU; Department of Oncology, University Children's Hospital Zürich, Zürich, Switzerland., Palmu S; Tampere Center for Child, Adolescent and Maternal Health Research, Faculty of Medicine and Health Technology, Tampere University and University Hospital, Tampere, Finland., Morgenstern DA; Division of Haematology/Oncology, Department of Paediatrics, Hospital for Sick Children and University of Toronto, Toronto, Ontario, Canada., Longhi A; Chemotherapy Service, Istituto Ortopedico Rizzoli, Istituto di Ricovero e Cura a Carattere Scientifico, Bologna, Italy., Baecklund F; Paediatric Oncology Unit, Karolinska University Hospital Solna, Stockholm, Sweden., Lee JA; Center for Pediatric Cancer, National Cancer Center, Goyang, Republic of Korea., Locatelli F; Department of Pediatric Hematology and Oncology, Istituto di Ricovero e Cura a Carattere Scientifico Ospedale Pediatrico Bambino Gesù, Catholic University of the Sacred Heart, Rome, Italy., Márquez Vega C; Department of Pediatric Oncology, Hospital Virgen del Rocío, Seville, Spain., Janeway KA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts., McCowage G; Cancer Centre for Children, The Children's Hospital at Westmead, Sydney, New South Wales, Australia., McCabe MG; Division of Cancer Sciences, The University of Manchester, Manchester, United Kingdom.; The Christie NHS Foundation Trust, Manchester, United Kingdom., Bidadi B; Clinical Research, Merck & Co Inc, Rahway, New Jersey., Huang J; Biostatistics, Eisai Inc, Nutley, New Jersey., McKenzie J; Oncology Business Group, Eisai Inc, Nutley, New Jersey., Okpara CE; Clinical Research, Eisai Ltd, Hatfield, United Kingdom., Bautista F; Hospital del Niño Jesús, Madrid, Spain.; Now with Princess Maxima Centrum for Pediatric Cancer, Utrecht, the Netherlands.
Publikováno v:
JAMA oncology [JAMA Oncol] 2024 Oct 17. Date of Electronic Publication: 2024 Oct 17.
Autor:
Seres R; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester M20 4BX, UK., Hameed H; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester M20 4BX, UK., McCabe MG; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester M20 4BX, UK.; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PL, UK., Russell D; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PL, UK.; Department of Radiology, Lancashire Teaching Hospitals NHS Trust, Chorley PR7 1PP, UK., Lee ATJ; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester M20 4BX, UK.; NHS England Highly Specialised Service for Complex Neurofibromatosis Type 1: Manchester, Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester M13 9WL, UK.
Publikováno v:
Cancers [Cancers (Basel)] 2024 Sep 26; Vol. 16 (19). Date of Electronic Publication: 2024 Sep 26.